• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性尿毒症对骨骼的影响。

Effects of chronic uremia on bone.

作者信息

Denneberg T, Johnell O, Nilsson B E, Wiklund P E

出版信息

Scand J Urol Nephrol. 1982;16(3):275-8. doi: 10.3109/00365598209179766.

DOI:10.3109/00365598209179766
PMID:7163791
Abstract

Iliac crest bone biopsies in patients with chronic renal failure with severely disturbed renal function were measured with regard to osteoclast activity and active and inactive osteoid. In none of the 21 patients had hemodialysis been applied. In uremia cases, as earlier demonstrated in hemodialysis cases, the alkaline phosphatase and the parathyroid hormone activity were the best variables for prediction of bone complications. However, none of the laboratory variables or all taken together could predict the type of bone changes. The osteoclast activity was less than in hemodialysis cases indicating that secondary hyperparathyroidism may be less important in the non-hemodialysed cases.

摘要

对肾功能严重受损的慢性肾衰竭患者的髂嵴骨活检进行了破骨细胞活性以及活性和非活性类骨质的测定。21例患者均未进行血液透析。与血液透析病例中早期所证实的情况一样,在尿毒症病例中,碱性磷酸酶和甲状旁腺激素活性是预测骨并发症的最佳变量。然而,无论是单个实验室变量还是所有变量综合起来,都无法预测骨变化的类型。破骨细胞活性低于血液透析病例,这表明继发性甲状旁腺功能亢进在未进行血液透析的病例中可能不那么重要。

相似文献

1
Effects of chronic uremia on bone.慢性尿毒症对骨骼的影响。
Scand J Urol Nephrol. 1982;16(3):275-8. doi: 10.3109/00365598209179766.
2
Bone changes in hemodialyzed uremic subjects. Comparative light and electron microscope investigations.血液透析的尿毒症患者的骨骼变化。光镜与电镜对比研究。
Virchows Arch A Pathol Anat Histol. 1976 Sep 21;371(3):183-98. doi: 10.1007/BF00433067.
3
Studies of bone morphology, bone densitometry and laboratory data in patients on maintenance hemodialysis treatment.维持性血液透析治疗患者的骨形态学、骨密度测定及实验室数据研究。
Nephron. 1985;39(2):122-9. doi: 10.1159/000183355.
4
[Effect of strontium on bone metabolism in hemodialysis patients].[锶对血液透析患者骨代谢的影响]
Nefrologia. 2003;23 Suppl 2:52-6.
5
A case of normocalcemic primary hyperparathyroidism with osteomalacia.一例伴有骨软化症的血钙正常的原发性甲状旁腺功能亢进症病例。
Endocrinol Jpn. 1986 Oct;33(5):575-82. doi: 10.1507/endocrj1954.33.575.
6
Azotaemic renal osteodystrophy: a quantitative study on iliac bone.氮质血症性肾性骨营养不良:髂骨的定量研究。
J Clin Pathol. 1973 Feb;26(2):83-101. doi: 10.1136/jcp.26.2.83.
7
Biochemical and morphological aspects of bone tissue in chronic renal failure.慢性肾衰竭时骨组织的生化及形态学特征
Nephron. 1974;12(6):437-48. doi: 10.1159/000180381.
8
Azotemic renal osteodystrophy; clinical features and bone pathology.
Endocrinol Jpn. 1979 Jun;26(Suppl):85-93. doi: 10.1507/endocrj1954.26.supplement_85.
9
Detection of osteomalacia in British Asians: a comparison of clinical score with biochemical measurements.
Clin Sci (Lond). 1990 Apr;78(4):383-9. doi: 10.1042/cs0780383.
10
Extent of alkaline phosphatase cytochemistry vs. extent of tetracycline fluorescence in the evaluation of histodynamic variables of bone formation.
Bone. 1995 May;16(5):493-8. doi: 10.1016/8756-3282(95)00079-s.